Cephalon Trims 1 Year Of Provigil Claims In FCA Suit
A Pennsylvania federal judge agreed Tuesday to peel a year's worth of claims from consolidated litigation over Cephalon Inc.'s alleged off-label promotion of its narcolepsy drug Provigil, finding that the federal...To view the full article, register now.
Already a subscriber? Click here to view full article